News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Licenses Axeda® Device Relationship Management Software to Remotely Support Pyxis® Products
05/02/2005

SAN DIEGO, May 2, 2005 - Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health care industry, has licensed technology from Axeda Systems, Inc. (NASDAQ: XEDAC), a leading provider of device relationship management (DRM) software and services. Cardinal Health will use the Axeda® DRM system for remote monitoring and proactive support of Pyxis® products deployed at customer locations worldwide. 

In addition to real-time, remote monitoring and service, Cardinal Health will use the Axeda® DRM system to deliver remote software upgrades and patches to Pyxis® products, as well as to run remote desktop sharing sessions and diagnostic programs for its customers. The Axeda® DRM system has strict security provisions that complement health care facilities' existing network security infrastructure including firewalls and intrusion detection systems.

"Providing our customers with superior service is a top priority for Cardinal Health,” said Lauren Abrams, senior vice president of customer support operations for the Clinical Technologies and Services segment of Cardinal Health. “By allowing us to remotely monitor, manage and service our products in a secure environment, the Axeda® DRM system will improve system uptime and enhance customer satisfaction."

"Health care providers rely on Pyxis® products for access to the medications and supplies necessary to provide timely, quality patient care," said Robert M. Russell Jr., chairman and chief executive officer of Axeda Systems. "The proactive monitoring and remote repair capabilities of the Axeda® DRM system is a natural match for the stringent uptime requirements of health care companies like Cardinal Health."

About Cardinal Health
Cardinal Health, Inc. (www.cardinalhealth.com) is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals and medical, surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 55,000 people on six continents and produces annual revenues of more than $65 billion.


Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 8-K and Form 10-Q reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the costs, difficulties, and uncertainties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships or changes to the terms of those relationships, changes in the distribution patterns or reimbursement rates for health-care products and/or services, the results, consequences, effects or timing of any inquiry or investigation by any regulatory authority or any legal and administrative proceedings, the impact of previously announced restatements, difficulties in opening new facilities or fully utilizing existing capacity, difficulties and uncertainties associated with business model transitions, including the conversion of margin generated from branded pharmaceutical manufacturers to non-contingent consideration, and general economic and market conditions. Cardinal Health undertakes no obligation to update or revise any forward-looking statement.

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields